Chewable Stimulant OK’d for ADHD
The FDA has approved a chewable tablet form of extended-release methylphenidate, to be sold as QuilliChew ER, for treatment of attention deficit-hyperactivity disorder (ADHD), according to manufacturer Pfizer.
Other Articles in this Edition
Chewable Stimulant OK’d for ADHD
A closer look at study reporting ADHD medications cause sleep problems
Using Ritalin to Treat ADHD: Expert Q&A
An ADHD Holiday: Managing the symptoms during the season
Bioequivalence for Generic ADHD Medications
Mental health risks highlighted in expectant fathers with epilepsy